Invitrogen Introduces Omnia™ Kinase Assays

Date Posted: Monday, May 29, 2006

Invitrogen Corporation has announced the launch of its Omnia™ Kinase Assays for the rapid, homogenous and sensitive detection of enzymatic activity under physiological ATP concentrations.

Scientists can mix reagents, read real-time fluorescent signals and get results in under an hour.

Omnia™ is designed to offer a simple mix and read procedure, streamlining assay set-up and speeding data collection.

Further Information: http://www.invitrogen.com

Request Information From Vendor

Related Products

Invitrogen Launches Biomarker Tool for Pre-Clinical Research into Kidney Function
New assay panel enables non-invasive kidney transplantation immune response and tolerance studies.

Invitrogen Launches new Microarray System to Simplify Immunogenetic Testing
Prodigy system advances process for HLA in stem cell and solid organ transplant research.

New T-Cell Expansion Medium Provides T-Cell Doubling in a Serum-Free Environment
Invitrogen launches of GIBCO® OpTmizer™ for culturing and expanding human T-cells that does not require the addition of serum to achieve optimal results.

Related news from our archive

Invitrogen Presents Latest Trends in Stem Cell Technologies at ISSCR Meeting
Tutorials provide insight into pioneering approaches for culture and expansion of multiple human cell types.

Invitrogen Earns Ameristar® Award for GIBCO® Cell Culture Bottle Design
The GIBCO bottle packaging was redesigned by Invitrogen to promote ease of use, efficient storage and reduced sample contamination.